NCT00098085View on ClinicalTrials.gov

Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

November 30, 2007

Conditions
Non-Small-Cell Lung CarcinomaLung CancerPulmonary Cancer
Interventions
BIOLOGICAL

HSPPC-96

Trial Locations (1)

Unknown

London

Sponsors

Lead Sponsor

Agenus Inc.
All Listed Sponsors
lead

Agenus Inc.

INDUSTRY